Farwell Wildon

Chief Medical Officer

1 company

Average

Trades Analyzed

12M Win Rate

58.8%

Avg 3M Return

-14.5%

Avg 12M Return

-8.0%

Farwell Wildon is a Chief Medical Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $3.0M based on current market prices.

Holdings by Company

DYNAug 19, 2024

Current Shares143.5K

Value$2.99M

Net Activity-46,271

Bought: 0Sold: 46.3K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 19, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	2,321	$45.12	$104,726.60	-0.8%	-36.4%	-73.4%
Jun 11, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	2,636	$31.27	$82,427.72	-0.9%	+4.9%	-52.9%
May 16, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	2,381	$28.27	$67,309.95	-0.8%	+52.6%	-58.9%
Mar 12, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	2,615	$25.65	$67,081.90	-0.9%	+16.2%	-54.4%
Mar 7, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	9,921	$25.86	$256,584.60	-3.1%	+24.4%	-53.1%
Feb 28, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	407	$25.00	$10,175.00	-0.2%	+20.1%	-47.3%
Feb 12, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	5,493	$25.07	$137,709.51	-3.3%	+9.5%	-44.4%
Jan 26, 2024	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	100	$25.00	$2,500.00	-	+12.0%	-35.2%
Dec 12, 2023	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	2,666	$10.66	$28,413.26	-0.8%	+133.1%	+150.6%
Sep 12, 2023	DYN Dyne Therapeutics, Inc.	Chief Medical Officer	Sell	1,707	$10.41	$17,769.87	-1.9%	+10.1%	+229.3%